alexa Predicting The Metabolic Future Of Children Using Fetal Glycated Hemoglobin, Anovel Biomarker
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Jean Luc Ardilouze
Accepted Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.028
Abstract
The lifetime risk of metabolic diseases in offspring of women with gestational diabetesmellitus (GDM) depends, at least in part, on the impact of glycemic fetal programming. To quantify this impact, we have developed and validated a unique mass-spectrometrymethod to measure the percentage of glycated hemoglobin in cord blood. This first casecontrolstudy includes 37 GDM women and 30 pregnant women with normal glucosetolerance (NGT). Glycation of the α-chain (Glα) was higher in neonates from GDM(2.32% vs. 2.20%; P<0.01). Glα strongly correlated with maternal A1c measured atdelivery in the overall cohort (r = 0.67; P<0.0001) as well as in each group (GDM: r =0.66; P<0.0001; NGT: r = 0.50; P=0.01). Thus, Glα may reflect hyperglycemic exposureduring the last weeks of fetal development. Future studies will confirm Glα is a predictivebiomarker of fetally programmed lifetime metabolic health and disease.
Biography
Jean-Luc Ardilouze studied medicine (Nantes, France, 1979), subsequently specializing in endocrinology (Montpelier, France, 1984). He completed a PhD at University of Oxford in 2004. He is currently a Full Professor of Medicine at the Faculty of Medicine of Sherbrooke (Canada).Dr. Ardilouze?s research examines gestational diabetes mellitus (GDM), the pharmacology of insulin,and the regulation of blood flow in adipose tissue. He is the principal investigator and coinvestigator in numerous research grants. He is author or co-author of more than 200 scientific publications,abstracts and articles.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords